Axogen, Inc.

Verified identity

Start with the filing record

The identity and ticker come from the SEC’s official company ticker mapping. Market and editorial coverage are not inferred from that record.

Ticker: AXGN
CIK: 0000805928
Exchange: Nasdaq
Universe updated: 2026-08-22

Open SEC filings

Market price

Latest quoteOpens Google

TickerGrove coverage

Latest on Axogen, Inc.

Companies

Axogen’s $200 million BioCircuit deal bets on wider adoption of sutureless nerve repair

BioCircuit brings $11 million in 2025 revenue and NerveTape to the proposed acquisition. Axogen’s stock offering is expected to raise about $195.5 million after underwriting discounts and estimated offering expenses.

Published 09-10-2026 · Axogen, Inc.

Research foundation

Read the filing with the right frame

Company analysis

Revenue, EPS and guidance answer different earnings questions

Revenue is the top-line amount recognized from a company’s activities under its accounting policy.

Earnings reading room →

Company analysis

The three financial statements describe one business from different angles

The income statement records revenue and expenses over a period.

Company research desk →

Investing basics

Stocks, ETFs and indexes are different objects

A stock is an ownership interest in one company.

Company research desk →